D-0162-2016 Class III Terminated
FDA drug recall D-0162-2016 was initiated by Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals on Oct 21, 2015 and is designated Class III. Reason for recall: Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben. The recall status is terminated (terminated Oct 23, 2016). Affected quantity: 61,146 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 11, 2015
- Initiation Date
- Oct 21, 2015
- Termination Date
- Oct 23, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 61,146 Bottles
Product description
RANITIDINE SYRUP (RANITIDINE ORAL SOLUTION, USP) 15 mg/mL (75 mg/5 mL), 473 mL (16 fl oz), Rx only. Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC: 0603-9418-58.
Reason for recall
Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.
Distribution pattern
U.S. Nationwide
Code information
Lot #: L088L13A, Expiry: 12/15; Lot #: L023F14A, Expiry: 5/16; Lot#: L024F14A, Expiry: 5/16.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0162-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026